Moneycontrol PRO
UPCOMING EVENT:Moneycontrol Pro & Espresso (A Sharekhan Company) in association with Intrazon 2.0 bring to you India’s Largest Retail Intraday Traders Online Conference. Learn 12 Amazing Strategies from 12 Intraday Traders @ Rs. 600/-. Register Now!
you are here: HomeNewsIndia

COVID-19 lockdown: Crop insurance claims worth Rs 2,424 crore disbursed to farmers

The Kisan Credit Card (KCC) saturation drive has been initiated by the ministry in collaboration with the Department of Financial Services to cover all PM-KISAN beneficiaries.

April 15, 2020 / 10:02 PM IST
Representative image

Representative image

The government on Wednesday said that crop insurance claims worth Rs 2,424 crore have been disbursed to farmers across 12 states during the lockdown period. The Union Agriculture Ministry said it has taken several other measures to facilitate farmers and farming activities at field level during the lockdown period.

Highlighting these measures, the ministry said that "under the Pradhan Mantri Fasal Bima Yojana (PMFBY), insurance claims amounting to Rs 2,424 crore have been disbursed to the beneficiary farmers in 12 states in the country."

The Kisan Credit Card (KCC) saturation drive has been initiated by the ministry in collaboration with the Department of Financial Services to cover all PM-KISAN beneficiaries.

"So far 83 lakh applications received out of which 18.26 lakh applications have been sanctioned for loan amount of Rs 17,800 crore," an official statement said.

The due date for conversion of agri-gold loan and other agri accounts into KCC Account was March 31 but now it has been extended up to May 31.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Follow our full coverage of the coronavirus pandemic here.
PTI

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark